These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 24909234)

  • 21. Advances in drug metabolism and pharmacogenetics research in Australia.
    Mackenzie PI; Somogyi AA; Miners JO
    Pharmacol Res; 2017 Feb; 116():7-19. PubMed ID: 27956261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reaction phenotyping: advances in the experimental strategies used to characterize the contribution of drug-metabolizing enzymes.
    Zientek MA; Youdim K
    Drug Metab Dispos; 2015 Jan; 43(1):163-81. PubMed ID: 25297949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytochrome P450s: mechanisms and biological implications in drug metabolism and its interaction with oxidative stress.
    Bhattacharyya S; Sinha K; Sil PC
    Curr Drug Metab; 2014; 15(7):719-42. PubMed ID: 25429675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of biotransformation studies in minimizing metabolism-related liabilities in drug discovery.
    Shu YZ; Johnson BM; Yang TJ
    AAPS J; 2008; 10(1):178-92. PubMed ID: 18446518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic-intermediate complex formation with cytochrome P450: theoretical studies in elucidating the reaction pathway for the generation of reactive nitroso intermediate.
    Taxak N; Desai PV; Patel B; Mohutsky M; Klimkowski VJ; Gombar V; Bharatam PV
    J Comput Chem; 2012 Aug; 33(21):1740-7. PubMed ID: 22610824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-based interpretation of biotransformation pathways of amide-containing compounds in sludge-seeded bioreactors.
    Helbling DE; Hollender J; Kohler HP; Fenner K
    Environ Sci Technol; 2010 Sep; 44(17):6628-35. PubMed ID: 20690778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Covalent thiol adducts arising from reactive intermediates of cocaine biotransformation.
    Schneider KJ; DeCaprio AP
    Chem Res Toxicol; 2013 Nov; 26(11):1755-64. PubMed ID: 24112049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enzyme-catalyzed bioactivation of cyclic tertiary amines to form potential neurotoxins.
    Castagnoli N; Castagnoli KP; Van der Schyf CJ; Usuki E; Igarashi K; Steyn SJ; Riker RR
    Pol J Pharmacol; 1999; 51(1):31-8. PubMed ID: 10389142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of the Biotransformation of Low-Turnover Drugs in the H
    Burton RD; Hieronymus T; Chamem T; Heim D; Anderson S; Zhu X; Hutzler JM
    Drug Metab Dispos; 2018 Nov; 46(11):1617-1625. PubMed ID: 30135244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cunninghamella Biotransformation--Similarities to Human Drug Metabolism and Its Relevance for the Drug Discovery Process.
    Piska K; Żelaszczyk D; Jamrozik M; Kubowicz-Kwaśny P; Pękala E
    Curr Drug Metab; 2016; 17(2):107-17. PubMed ID: 26526834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on the oxidation of 1,4-disubstituted-1,2,3,6-tetrahydropyridines.
    Castagnoli N; Castagnoli K; Magnin G; Kuttab S; Shang J
    Drug Metab Rev; 2002 Aug; 34(3):533-47. PubMed ID: 12214665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trimethoprim: novel reactive intermediates and bioactivation pathways by cytochrome p450s.
    Damsten MC; de Vlieger JS; Niessen WM; Irth H; Vermeulen NP; Commandeur JN
    Chem Res Toxicol; 2008 Nov; 21(11):2181-7. PubMed ID: 18816075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel advances in biotransformation and bioactivation research-2019 year in review
    Khojasteh SC; Driscoll JP; Jackson KD; Miller GP; Mitra K; Rietjens IMCM; Zhang D
    Drug Metab Rev; 2020 Aug; 52(3):333-365. PubMed ID: 32645275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of bioactivation in drug-induced hypersensitivity reactions.
    Sanderson JP; Naisbitt DJ; Park BK
    AAPS J; 2006 Feb; 8(1):E55-64. PubMed ID: 16584134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of biotransformation and bioactivation in toxicity.
    Dekant W
    EXS; 2009; 99():57-86. PubMed ID: 19157058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conventional and novel approaches in generating and characterization of reactive intermediates from drugs/drug candidates.
    Orhan H; Vermeulen NP
    Curr Drug Metab; 2011 May; 12(4):383-94. PubMed ID: 21395525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytochromes P450 catalyze both steps of the major pathway of clopidogrel bioactivation, whereas paraoxonase catalyzes the formation of a minor thiol metabolite isomer.
    Dansette PM; Rosi J; Bertho G; Mansuy D
    Chem Res Toxicol; 2012 Feb; 25(2):348-56. PubMed ID: 22103858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of cytochrome P450 enzymes and biochemical aspects of mechanism-based inactivation (MBI).
    Kamel A; Harriman S
    Drug Discov Today Technol; 2013; 10(1):e177-89. PubMed ID: 24050247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The metabolism of tertiary amines.
    Rose J; Castagnoli N
    Med Res Rev; 1983; 3(1):73-88. PubMed ID: 6341732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of novel dihydrothienopyridinium and thienopyridinium metabolites of ticlopidine in vitro: role of peroxidases, cytochromes p450, and monoamine oxidases.
    Dalvie DK; O'Connell TN
    Drug Metab Dispos; 2004 Jan; 32(1):49-57. PubMed ID: 14709620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.